We’re stopping outbreaks from taking off.

In the early days of the COVID-19 pandemic, XpresCheck established COVID-19 testing facilities in airports across the United States. Over the course of 3+ years, we tested more than 200,000 people. As the spread of COVID-19 slowed, and travel restrictions were lifted, we transitioned our efforts to the US CDC Traveler-Based Genomic Surveillance (TGS) Program.

XpresCheck, in collaboration with the Centers for Disease Control and Prevention (CDC), is now performing bio surveillance at U.S. airports across the country. This voluntary blind testing of incoming international fliers helps to detect new variants of COVID-19 and other emerging infectious diseases.

We test 6,000+ travelers who arrive in the United States from 135 different countries approximately 1,400 flights every week for COVID-19 and various multi pathogens. Our mission has always been to help keep people safe and protected.

To learn more Visit Us